Search

Author/Creator Lachno, David Richard

1. [IC‐P‐043]: EFFECT OF SOLANEZUMAB ON BIOMARKERS OF NEURODEGENERATION IN THE EXPEDITION3 TRIAL IN MILD ALZHEIMER DISEASE. (1st July 2017)

Authors:
Schwarz, Adam J.; Sundell, Karen L.; Lachno, David Richard; Case, Michael G.; Suhy, Joyce; Pontecorvo, Michael J.; Dean, Robert A.; Siemers, Eric R.
Journal:
Alzheimer's & dementia
Issue:
Volume 13:Supplement 7S(2017)Part 1
Page Start:
P37
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. [P1–042]: PLASMA PHARMACOKINETICS AND PHARMACODYNAMICS OF SOLANEZUMAB IN MILD AND MODERATE AD PATIENTS. (1st July 2017)

Authors:
Willis, Brian A.; Ferguson‐Sells, Lisa R.; Chua, Laiyi; Siemers, Eric R.; Dean, Robert A.; Lachno, David Richard; Carlson, Christopher D.; Hake, Ann Marie; Hoffmann, Vicki P.; Friedrich, Stuart W.
Journal:
Alzheimer's & dementia
Issue:
Volume 13:Supplement 7S(2017)Part 5
Page Start:
P250
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. [P1–049]: SOLANEZUMAB CENTRAL TARGET ENGAGEMENT AND PHARMACODYNAMIC ACTIVITY IN THE EXPEDITION 3 TRIAL OF PATIENTS WITH MILD AD: COMPARISON TO EXPEDITION/EXPEDITION 2. (1st July 2017)

Authors:
Dean, Robert A.; Sundell, Karen L.; Lachno, David Richard; Ferguson‐Sells, Lisa R.; Case, Michael G.; Holdridge, Karen C.; Demattos, Ronald B.; Raskin, Joel; Siemers, Eric R.; Willis, Brian A.
Journal:
Alzheimer's & dementia
Issue:
Volume 13:Supplement 7S(2017)Part 5
Page Start:
P254
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. [P2–002]: EFFECT OF SOLANEZUMAB ON BIOMARKERS OF NEURODEGENERATION IN THE EXPEDITION3 TRIAL IN MILD ALZHEIMER DISEASE. (1st July 2017)

Authors:
Schwarz, Adam J.; Sundell, Karen L.; Lachno, David Richard; Case, Michael G.; Suhy, Joyce; Pontecorvo, Michael J.; Dean, Robert A.; Siemers, Eric R.
Journal:
Alzheimer's & dementia
Issue:
Volume 13:Supplement 7S(2017)Part 12
Page Start:
P605
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. [P4–155]: DERIVING A CUT‐OFF FOR THE ELECSYS® β‐AMYLOID (1–42) IMMUNOASSAY FOR USE IN CLINICAL TRIALS SUPPORTED BY ELI LILLY FOR PATIENTS WITH CLINICALLY DEFINED ALZHEIMER's DISEASE (AD). (1st July 2017)

Authors:
Shaw, Leslie M.; Waligorska, Teresa; Fields, Leona; Korecka, Magdalena; Figurski, Michal J.; Trojanowski, John Q.; Eichenlaub, Udo; Wahl, Simone; Quan, Marian; Lachno, David Richard; Talbot, Jayne A.; Andersen, Scott W.; Siemers, Eric R.; Dean, Robert A.
Journal:
Alzheimer's & dementia
Issue:
Volume 13:Supplement 7S(2017)Part 27
Page Start:
P1317
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗